Tumor necrosis factor gene and microsatellite polymorphism in chronic inflammatory bowel diseases.

被引:0
作者
Heresbach, D
Ababou, A
Bourienne, A
Alizadeh, M
Quelvennec, E
Pagenault, M
Dabadie, A
HeresbachLeBerre, N
Campion, JP
Launois, B
Gosselin, M
Genetet, B
Bretagne, JF
Semana, G
机构
[1] CHRU PONTCHAILLOU,SERV HEPATOGASTROENTEROL,RENNES,FRANCE
[2] CHRU PONTCHAILLOU,SERV PEDIAT,RENNES,FRANCE
[3] CHRU PONTCHAILLOU,CLIN CHIRURG B,RENNES,FRANCE
[4] ETABLISSEMENT TRANSFUS SANGUINE BRETAGNE EST,LAB UNIV IMMUNOL,RENNES,FRANCE
来源
GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE | 1997年 / 21卷 / 8-9期
关键词
inflammatory bowel disease; Crohn's disease; microsatellites; tumor necrosis factor;
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Objectives. - Multiplex family studies have excluded chromosome 6 as a candidate gene of susceptibility to inflammatory bowel disease. However one recent study suggested that a gene involved in the pathogenesis of Crohn's disease is located on chromosome 6 confering to a microsatellite allelic combination (a2, b1, c2, d4, e1) a strong genetic risk factor in Crohn's disease. The aim of our study was to determine simultaneously the polymorphisms of the TNF microsatellites and of the the genes coding for TNF synthesis in patients with inflammatory bowel disease. Patients and methods. - Sixty patients with ulcerative colitis, 100 patients with Crohn's disease were compared to 64 healthy ethnically matched controls. Five TNF microsatellite loci (a, b, c, d, e) were typed using polymerase chain reaction PCR, and two dimorphisms of TNF alpha and TNF beta (intron 1) were studied by restriction fragment length polymorphism (RFLP). Results. - Allelic frequencies of TNF microsatellites and of TNF alpha and beta genes were similar in Crohn's disease, ulcerative colitis and controls. Five loci microsatellite haplotypes, especially a2 b1 c2 d4 e1 allelic combination, were not more frequent in Crohn's disease (25 %) compared to ulcerative colitis (27 %) or controls (20 %). Subgroups stratification according to clinical characteristics did not modify haplotype frequencies. Analysis of our data taking simultaneously into account the MHC alleles (DRB1*01 or DRB1*04) did not modify our data ; however it suggested that extended haplotype on short arm of chromosome 6 differed between patients and controls. Linkage disequilibrium (Delta = -360.10(-4); P < 0.01) between a2, b1, c2, d4, e1 allelic combination and DRB1*04 allele was observed only in Crohn's disease. Conclusion. - Percentages of patients with Crohn's disease or ulcerative colitis carrying TNF microsatellite or TNF alpha and beta gene haplotypes were similar to those of healthy controls. These data argue against involvement of the TNF locus without exclusion of short arm of chromosome 6 implication in Crohn's disease pathogenesis.
引用
收藏
页码:555 / 561
页数:7
相关论文
共 50 条
[41]   Tumor necrosis factor-α gene polymorphism in reflux nephropathy [J].
Solari, V ;
Ennis, S ;
Cascio, S ;
Puri, P .
JOURNAL OF UROLOGY, 2004, 172 (04) :1604-1606
[42]   Systematic Review of Tumor Necrosis Factor Antagonists in Extraintestinal Manifestations in Inflammatory Bowel Disease [J].
Peyrin-Biroulet, Laurent ;
Van Assche, Gert ;
Gomez-Ulloa, David ;
Garcia-Alvarez, Laura ;
Lara, Nuria ;
Black, Chris M. ;
Kachroo, Sumesh .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2017, 15 (01) :25-+
[43]   Comparative Risk of Serious Infections With Tumor Necrosis Factor α Antagonists vs Vedolizumab in Patients With Inflammatory Bowel Diseases [J].
Singh, Siddharth ;
Heien, Herbert C. ;
Herrin, Jeph ;
Dulai, Parambir S. ;
Sangaralingham, Lindsey ;
Shah, Nilay D. ;
Sandborn, William J. .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2022, 20 (02) :E74-E88
[44]   Metabolic Functions of Gut Microbes Associate With Efficacy of Tumor Necrosis Factor Antagonists in Patients With Inflammatory Bowel Diseases [J].
Aden, Konrad ;
Rehman, Ateequr ;
Waschina, Silvio ;
Pan, Wei-Hung ;
Walker, Alesia ;
Lucio, Marianna ;
Nunez, Alejandro Mena ;
Bharti, Richa ;
Zimmerman, Johannes ;
Bethge, Johannes ;
Schulte, Berenice ;
Schulte, Dominik ;
Franke, Andre ;
Nikolaus, Susanna ;
Schroeder, Johann Oltmann ;
Vandeputte, Doris ;
Raes, Jeroen ;
Szymczak, Silke ;
Waetzig, Georg H. ;
Zeuner, Rainald ;
Schmitt-Kopplin, Philippe ;
Kaleta, Christoph ;
Schreiber, Stefan ;
Rosenstiel, Philip .
GASTROENTEROLOGY, 2019, 157 (05) :1279-+
[45]   Listeria monocytogenes infection in patients with inflammatory bowel diseases receiving anti-tumor necrosis factor therapy [J].
Ramos, J. M. ;
Garcia-Sepulcre, M. F. ;
Masia, M. ;
Brotons, A. ;
Grau, M. C. ;
Gutierrez, F. .
REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2010, 102 (10) :614-U62
[46]   Effects of tumor necrosis factor-857C/T polymorphism on the expression of tumor necrosis factor [J].
Kimura, Koji ;
Takayanagi, Risa ;
Yokoyama, Haruko ;
Yamada, Yasuhiko .
APMIS, 2016, 124 (08) :669-674
[47]   Thioguanine Therapy in Inflammatory Bowel Diseases. A Practical Guide [J].
Crouwel, Femke ;
Simsek, Melek ;
Mulder, Chris J. J. ;
Buiter, Hans J. C. ;
de Boer, Nanne K. .
JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2020, 29 (04) :637-645
[48]   Tumour necrosis factor antagonists and inflammatory bowel diseases: a national practice survey [J].
Oussalah, A. ;
Roblin, X. ;
Laharie, D. ;
Filippi, J. ;
Flamant, M. ;
Faure, P. ;
Phelip, J. -M. ;
Bigard, M. -A. ;
Peyrin-Biroulet, L. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2009, 30 (08) :854-863
[49]   Drug insight:: Antagonists of tumor-necrosis factor-α in the treatment of inflammatory bowel disease [J].
Chang, JT ;
Lichtenstein, GR .
NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY, 2006, 3 (04) :220-228
[50]   Bactericidal Permeability Increasing Protein Gene Polymorphism is Associated with Inflammatory Bowel Diseases in the Turkish Population [J].
Can, Guray ;
Akin, Hakan ;
Ozdemir, Filiz T. ;
Can, Hatice ;
Yilmaz, Bulent ;
Eren, Fatih ;
Atug, Ozlen ;
Unsal, Belkis ;
Hamzaoglu, Hulya O. .
SAUDI JOURNAL OF GASTROENTEROLOGY, 2015, 21 (04) :239-244